|Bid||322.20 x 1100|
|Ask||322.30 x 800|
|Day's Range||318.50 - 341.55|
|52 Week Range||65.49 - 497.49|
|Beta (5Y Monthly)||1.49|
|PE Ratio (TTM)||38.30|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for MRNALearn more
Over the past 10 years, U.S. stocks have delivered outstanding returns for investors. The major stock indices such as the Dow Jones Industrial Average, the NASDAQ Composite, and the S&P 500 have all climbed by more than 200% during this boom period. For example, biotech innovators Axsome Therapeutics (NASDAQ: AXSM) and Moderna (NASDAQ: MRNA), along with electric-car giant Tesla (NASDAQ: TSLA), have all generated well over 1,000% returns on capital for investors in just the past three years.
The Alaska Department of Revenue sold most of its GameStop stock in the third quarter. It initiated positions in Moderna and Palantir stock, and bulked up its holdings in Analog Devices stock.
The company's COVID-19 vaccine has been a massive success, but how much is the underlying technology worth?